Vimarsana
Biggest News Aggregation in the World

Veracyte Diagnostics Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Veracyte Diagnostics Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Veracyte Diagnostics Platform Today - Breaking & Trending Today

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024 - Vimarsana News

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024

Veracyte, Inc. announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial results and...

New Study Shows Veracyte's Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance - Vimarsana News

New Study Shows Veracyte's Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

Veracyte, Inc. , a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance for prostate...

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024 - Vimarsana News

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024

Veracyte, Inc. announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call...

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024 - Vimarsana News

Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024

22.04.2024 - Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and webcast to discuss financial ...

Veracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines -February 27, 2024 at 05:56 pm EST - Vimarsana News

Veracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines -February 27, 2024 at 05:56 pm EST

Veracyte, Inc. , a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene expression test to receive a “Level 1B” evidence rating in...